Skip to main content
Clinical Trials/NCT02884362
NCT02884362
Recruiting
Not Applicable

Creation of a Prospective Melanoma Database

Institut Claudius Regaud1 site in 1 country10,000 target enrollmentJanuary 2016
ConditionsMelanoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Melanoma
Sponsor
Institut Claudius Regaud
Enrollment
10000
Locations
1
Primary Endpoint
Database of patients with melanoma
Status
Recruiting
Last Updated
9 years ago

Overview

Brief Summary

In research on melanoma, translational research is the essential link between basic research and clinical research by facilitating the passage between discovery and improvement in the quality of patients care.That is the reason why it is very important to collect, and centralize clinical and biological data of patients with melanoma.

The aim of the project is to provide to scientific community a structured, mixed clinical and biological database, unique in France, in order to insure accessibility to clinical data.

Detailed Description

collection of clinical and biological data from patients with melanomas of any stage in a structured and centralized database

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
June 2026
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Histologically confirmed melanoma of any stage
  • Affiliated to a social security system in france
  • Who signed the informed consent

Exclusion Criteria

  • Any psychiatric or medical condition that would make the patient unable to give a signed informed consent

Outcomes

Primary Outcomes

Database of patients with melanoma

Time Frame: 10 years

Study Sites (1)

Loading locations...

Similar Trials